Galenica AG
SIX:GALE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
76.85
99.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CH |
|
Galenica AG
SIX:GALE
|
4.9B CHF |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
104.2B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.9B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
68.8B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.6B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
33.6B AUD |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
67.5B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.2B CNY |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.1B HKD |
Loading...
|
Market Distribution
| Min | -62 472.2% |
| 30th Percentile | 3.5% |
| Median | 10.3% |
| 70th Percentile | 16.5% |
| Max | 91.2% |
Other Profitability Ratios
Galenica AG
Glance View
In the picturesque landscape of Switzerland, Galenica AG operates as a stalwart in the healthcare sector, seamlessly bridging the gap between pharmaceutical production and retail distribution. Born from a deep-rooted legacy in delivering health solutions, Galenica combines its prowess in logistics with an extensive network of pharmacies spread across the country. The magic of Galenica's operations lies in its unique dual structure. On one hand, it operates a robust logistics arm, supplying a wide array of medicines to healthcare providers, hospitals, and pharmacies. On the other hand, it runs its own retail pharmacy chains, such as Amavita and Sun Store, alongside an e-commerce platform, which make pharmaceutical care more accessible and customer-friendly for the Swiss populace. Galenica's profitability thrives on this diversified business model. By owning the supply chain from logistics to retail, the company maximizes efficiency and reduces costs, positioning itself as a leader in the Swiss pharmaceutical market. Revenue streams flow from wholesale distribution contracts, retail pharmacy sales, and a growing presence in digital health services. Furthermore, in its operations, Galenica integrates a customer-centric philosophy, leveraging data analytics to optimize stock management and personalize customer experiences—effectively enhancing earnings and customer loyalty. Through meticulous execution and strategic expansion, Galenica ensures that it remains an indispensable player in Switzerland's healthcare framework.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Galenica AG is 5.3%, which is above its 3-year median of 5.2%.
Over the last 3 years, Galenica AG’s Operating Margin has decreased from 5.4% to 5.3%. During this period, it reached a low of 4.9% on Jun 30, 2023 and a high of 5.4% on May 30, 2022.